Total Payments
$88,785
2023 Payments
$4,873
Companies
11
Transactions
81
Medicare Patients
120
Medicare Billing
$9,350
Payment Breakdown by Category
Other$38,068 (42.9%)
Consulting$25,644 (28.9%)
Travel$23,149 (26.1%)
Food & Beverage$1,867 (2.1%)
Education$57.27 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,390 | 13 | 39.9% |
| Consulting Fee | $25,644 | 6 | 28.9% |
| Travel and Lodging | $23,149 | 26 | 26.1% |
| Honoraria | $2,678 | 1 | 3.0% |
| Food and Beverage | $1,867 | 33 | 2.1% |
| Education | $57.27 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $50,487 | 42 | $0 (2019) |
| Boehringer Ingelheim Mexico SA de CV | $13,583 | 7 | $0 (2020) |
| Dexcom, Inc. | $7,822 | 5 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $7,035 | 6 | $0 (2022) |
| Eli Lilly and Company | $5,315 | 11 | $0 (2019) |
| Boehringer Ingelheim Del Ecuador Cia. Ltda. | $1,700 | 1 | $0 (2020) |
| Boehringer Ingelheim Peru S.A.C | $1,500 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $1,074 | 1 | $0 (2019) |
| Novo Nordisk Inc | $155.65 | 4 | $0 (2022) |
| Abbott Laboratories | $87.50 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $4,873 | 2 | Dexcom, Inc. ($4,873) |
| 2022 | $1,432 | 3 | SANOFI-AVENTIS U.S. LLC ($1,250) |
| 2021 | $3,550 | 4 | DEXCOM, INC. ($2,800) |
| 2020 | $4,600 | 3 | Boehringer Ingelheim Del Ecuador Cia. Ltda. ($1,700) |
| 2019 | $20,624 | 28 | Merck Sharp & Dohme Corporation ($14,235) |
| 2018 | $21,090 | 18 | Merck Sharp & Dohme Corporation ($15,674) |
| 2017 | $32,615 | 23 | Merck Sharp & Dohme Corporation ($20,578) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2023 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Consulting Fee | Cash or cash equivalent | $4,760.00 | General |
| Category: Endocrinology | ||||||
| 06/22/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $112.50 | General |
| Category: Endocrinology | ||||||
| 09/12/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,250.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/30/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $149.86 | General |
| Category: Endocrinology | ||||||
| 03/09/2022 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 10/18/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $500.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/18/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $250.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/15/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Honoraria | Cash or cash equivalent | $2,678.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/09/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $121.92 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/14/2020 | Boehringer Ingelheim Del Ecuador Cia. Ltda. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,700.00 | General |
| Category: DIABETES | ||||||
| 07/16/2020 | Boehringer Ingelheim Peru S.A.C | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: DIABETES | ||||||
| 05/30/2020 | Boehringer Ingelheim Mexico SA de CV | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: DIABETES | ||||||
| 10/21/2019 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| 10/21/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 10/04/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $142.81 | General |
| 10/04/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $65.00 | General |
| 10/04/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 10/04/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 10/03/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $307.91 | General |
| 10/03/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $165.30 | General |
| 08/06/2019 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $4,987.50 | General |
| 06/28/2019 | Merck Sharp & Dohme Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| 06/28/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 06/27/2019 | Eli Lilly and Company | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $83.00 | General |
| Category: Diabetes | ||||||
| 06/27/2019 | Eli Lilly and Company | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 16 | 17 | $4,607 | $1,244 |
| 2022 | 1 | 25 | 29 | $7,859 | $2,150 |
| 2021 | 2 | 44 | 61 | $16,942 | $4,618 |
| 2020 | 1 | 35 | 38 | $9,158 | $1,339 |
Total Patients
120
Total Services
145
Medicare Billing
$9,350
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 17 | $4,607 | $1,244 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 25 | 29 | $7,859 | $2,150 | 27.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 16 | 29 | $8,817 | $2,362 | 26.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 28 | 32 | $8,125 | $2,256 | 27.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 35 | 38 | $9,158 | $1,339 | 14.6% |
About Dr. Francisco Pasquel, MD
Dr. Francisco Pasquel, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1417117003.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Francisco Pasquel, MD has received a total of $88,785 in payments from pharmaceutical and medical device companies, with $4,873 received in 2023. These payments were reported across 81 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($35,390).
As a Medicare-enrolled provider, Pasquel has provided services to 120 Medicare beneficiaries, totaling 145 services with total Medicare billing of $9,350. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Atlanta, GA
- Active Since 06/17/2008
- Last Updated 10/14/2014
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1417117003
Products in Payments
- JARDIANCE (Drug) $9,930
- TRADJENTA (Drug) $6,852
- SOLIQUA (Drug) $4,949
- DEXCOM G7 GSS (161) (Medical Supply) $4,760
- DEXCOM G6 TRANSMITTER (Device) $2,800
- SOLIQUA 100/33 (Biological) $2,000
- FARXIGA (Drug) $1,074
- V114 (Biological) $941.36
- PNEUMOVAX 23 (Biological) $510.30
- TRULICITY (Drug) $327.77
- Dexcom G6 Transmitter (Medical Supply) $262.36
- JANUVIA (Drug) $125.37
- FreeStyle Libre Pro (Device) $87.50
- TOUJEO (Drug) $85.82
- Santyl (Drug) $25.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Atlanta
Bruce Bode, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $2.9M
Endocrinology, Diabetes & Metabolism $2.9M
David Robertson, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $2.0M
Endocrinology, Diabetes & Metabolism $2.0M
Jonathan Ownby, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $297,304
Endocrinology, Diabetes & Metabolism $297,304
Guillermo Umpierrez, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $103,343
Endocrinology, Diabetes & Metabolism $103,343
Priyathama Vellanki, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $61,485
Endocrinology, Diabetes & Metabolism $61,485
Dr. Scott Isaacs, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $57,100
Endocrinology, Diabetes & Metabolism $57,100